Yes, adults can get RSV (respiratory syncytial virus). In fact, most adults have had an RSV infection at least once in their lives. This seasonal virus is so widespread that almost all of us have had ...

Over the course of a two-day meeting, vaccine advisers to the US Food and Drug Administration voted in favor of approval for RSV vaccines for adults over the age of 60. The vaccine candidates, made by ...

Data shows that ER visits and hospital admissions for RSV have been climbing in New Jersey since early October. Currently, ER ...

"Current vaccine recommendations continue to stratify by age but need to better incorporate risk from the presence of chronic medical conditions at any age." — Angela Branche, MD, Associate Professor ...

This week in JAMA Network Open, a team led by researchers from respiratory syncytial virus (RSV) vaccine-maker Pfizer ...

RSV hospitalization rates in older adults reached 58.3 per 100,000 in winter 2023-24, nearly half the rate of influenza at 114.6 per 100,000. Mortality and clinical outcomes were comparable between ...

RSV vaccination for adults aged 60+ could prevent significant LRTD cases, hospitalizations, and deaths over five years. A 5-percentage-point increase in vaccine uptake could avert over 222,000 LRTD ...

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are ...

New Jersey health data shows RSV activity continuing statewide, with hospitalizations concentrated among young children and older adults.

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study. The phase 3 randomized controlled trial ...